January 24, 2025 – The cryptocurrency market in 2025 is rapidly evolving, and investors are more eager than ever to participate in the thriving digital asset ecosystem. As Bitcoin and other cryptocurrencies surge in value, the demand for secure and trustworthy trading platforms has never been higher. At IJEX Exchange, we understand the importance of building trust and maintaining the highest security standards in an ever-changing market.

With geopolitical shifts, particularly the re-election of Donald Trump as the U.S. President, the global financial landscape is set to change. This shift will likely bring new regulatory measures that could either enhance or challenge the growth of cryptocurrencies. Against this backdrop, it is more critical than ever for investors to choose a platform that offers stability, transparency, and the necessary compliance to navigate this uncertain future.

IJEX Exchange stands out not only for its robust security but also for its commitment to regulatory excellence. In addition to holding the prestigious U.S. MSB certification, we are also certified by Canada’s FINTRAC and Singapore’s ACRA. These certifications reflect our adherence to the highest global standards in financial services, reinforcing our reputation as a reliable and trusted partner for both retail and institutional investors.

A Platform You Can Trust

At IJEX Exchange, we take compliance and security seriously. The MSB certification, alongside our FINTRAC and ACRA certifications, ensures that we operate with the utmost integrity, following strict anti-money laundering (AML) and Know-Your-Customer (KYC) procedures. This multi-jurisdictional certification strategy enhances the credibility of our platform, providing investors with the confidence they need to trade securely and reliably.

These certifications are a mark of excellence in the crypto industry, demonstrating our commitment to operating within the regulatory frameworks of the U.S., Canada, and Singapore. By aligning ourselves with these leading financial authorities, we offer a secure and compliant environment where investors can feel safe knowing that their transactions and assets are protected.

Why Choose IJEX Exchange?

1. Global Certifications: IJEX Exchange holds certifications from the U.S. MSB, Canada’s FINTRAC, and Singapore’s ACRA, ensuring full compliance with international financial regulations.
2. Advanced Security Protocols: We employ state-of-the-art security measures to safeguard user data and assets, providing a secure trading environment.
3. User-Friendly Platform: Whether you’re a first-time investor or an experienced trader, IJEX Exchange offers a seamless and intuitive platform to meet your trading needs.
4. Global Reach: Our platform offers access to a wide range of cryptocurrencies and trading pairs, serving investors worldwide.
5. Dedicated Support: Our expert support team is available around the clock, ready to assist with any questions or concerns that arise.

A Bright Future in Crypto

With 2025 ushering in new opportunities for cryptocurrency and a more favorable regulatory environment for digital assets, now is the perfect time to be involved. IJEX Exchange’s robust security and compliance practices, coupled with our global certifications, position us as a reliable and trusted partner in this growing market.

As we move forward, IJEX Exchange remains committed to maintaining the highest standards in the industry, ensuring that our platform provides the security, transparency, and support that investors need to thrive in the ever-evolving crypto space.

Contact Information:

Company Name: IJEX Exchange LTD.

Contact person: Henry Sullivan

Email: support@ijex.com

Website: https://ijex.com/ 

FinCEN MSB Registration Number: 31000257059546

FINTRAC MSB Registration Number: M24884993

January 24, 2025 – The year 2025 promises to be a transformative period for the cryptocurrency market, as Bitcoin soars to new record highs, sparking renewed global interest and excitement. Amid this surge, TXEX Exchange continues to solidify its reputation as a trusted and reliable platform by enhancing its security protocols and ensuring compliance with the highest standards. Recently, TXEX Exchange earned the prestigious MSB (Money Services Business) certification from the U.S. Department of Treasury, further reinforcing its commitment to providing a safe and secure trading environment for its users.

With Bitcoin breaking past the $100,000 mark, the dynamics of the global financial markets are evolving. As the world witnesses significant political shifts, particularly with the re-election of Donald Trump as the U.S. president, the landscape for digital currencies is set to change dramatically. The new administration’s approach to fiscal policy and regulation could have far-reaching implications for the future of cryptocurrency, driving demand for exchanges that adhere to robust security and regulatory standards.

As cryptocurrencies gain momentum in 2025, TXEX Exchange stands at the forefront, offering a secure, compliant, and user-friendly platform for both individual investors and high-net-worth clients. With the MSB certification in hand, TXEX Exchange sets itself apart as a leader in the industry, ensuring that clients’ assets are safeguarded with the highest level of care.

Strengthening Trust with MSB Certification

The MSB certification is an essential credential for any exchange looking to operate with transparency and in full compliance with U.S. financial regulations. For TXEX Exchange, this certification signifies a robust commitment to anti-money laundering (AML) standards, customer verification (KYC), and overall operational integrity. Investors can feel confident knowing that TXEX Exchange adheres to strict regulatory requirements, providing an extra layer of trust in a volatile market.

Why TXEX Exchange?

1. Compliance with U.S. Standards: With MSB certification, TXEX Exchange ensures full compliance with U.S. financial regulations, offering investors peace of mind.
2. State-of-the-Art Security: TXEX Exchange employs top-tier security measures to protect user assets and personal information, making it a trusted platform for traders.
3. Seamless Trading Experience: Our platform is designed to offer an efficient and secure trading environment, capable of handling large volumes of transactions with ease.
4. Global Reach and Support: Serving investors around the world, TXEX Exchange offers a comprehensive suite of cryptocurrencies and trading pairs.
5. Expert Assistance: Whether you’re just starting or are an experienced trader, our dedicated support team is always available to assist with your trading needs.

Conclusion: A Secure Future for Cryptocurrency Trading

With Bitcoin’s remarkable rise and the political landscape shifting under the influence of the newly re-elected U.S. president, the cryptocurrency market is more exciting and uncertain than ever before. Now, more than ever, it is essential to choose an exchange that is committed to maintaining the highest levels of security and regulatory compliance. TXEX Exchange’s MSB certification is a testament to our dedication to providing a trustworthy platform for our users.

As we look ahead to the opportunities and challenges of 2025, TXEX Exchange is committed to staying at the cutting edge of the industry, ensuring that our users have access to a secure and reliable trading environment that supports their investment goals.

Contact Information:

Company Name: TX Exchange

Contact person: Sophia Mitchell

Email: support@txex.com

Website: https://txex1.com/ 

MSB Registration Number: 31000269479677

Introducing ThymoTropin: A Groundbreaking OTC Solution for Muscle Health by Veos Pharmaceuticals

MADRID, Spain, 21st Jan 2025, – Veos Pharmaceuticals, a leading innovator with a portfolio of nearly 40 products across the EU, US, and Canada, today announced the launch of ThymoTropin, a revolutionary over-the-counter (OTC) solution for muscle growth, repair, and preservation. ThymoTropin, powered by clinically validated thymol and carvacrol, is the first product of its kind targeting myostatin regulation, a crucial mechanism for maintaining muscle mass and performance.

As part of Veos Pharma’s commitment to delivering science-backed innovations, ThymoTropin addresses the unique needs of individuals experiencing muscle loss due to aging, chronic disease, or weight management regimens, including GLP-1 treatments and calorie-restricted diets.

Filling a Critical Gap in Muscle Health:

More than 50% of individuals undergoing weight loss or battling chronic illnesses face muscle loss, impacting their mobility, strength, and overall health. ThymoTropin is formulated to counteract this decline by preserving and enhancing muscle mass through its innovative dual-action mechanism:

• Clinically proven myostatin regulation for targeted muscle preservation.
• Support for lean muscle growth and endurance, validated through preclinical and clinical studies.

“At Veos Pharmaceuticals, we are committed to addressing critical health gaps with effective, science-driven solutions,” said Dr. Bassam Damaj, Executive Chairman of Veos Pharma. “ThymoTropin is a game-changer in muscle health, offering proven benefits for individuals managing muscle loss while aligning with modern health goals, including weight loss and ageing-related care.”

Clinically Backed, Patented Innovation:

ThymoTropin is supported by a robust patent portfolio, including:

• US Patent No. 11,135,178: Enhancing Muscle Growth via Monoterpenes
• CA Patent No. 2,964,239: Applications of Monoterpenes in Muscle Health
• EP Patent No. 3191086: Monoterpene Formulations for Muscle Enhancement
• PT Patent No. 3191086: Monoterpenes for Myostatin Regulation

Clinical results demonstrate up to a 50% increase in muscle mass and a 37% improvement in endurance. ThymoTropin’s unique focus on myostatin regulation differentiates it from traditional protein supplements, making it a superior solution for muscle health.

Targeted Nutrition for Growing Market Needs:

The global market for muscle health and repair products continues to grow, driven by increasing demand from aging populations, oncology patients, and fitness-conscious individuals. ThymoTropin directly addresses these needs by providing:

• Muscle preservation during weight loss
• Enhanced recovery and repair
• Support for aging-related muscle decline

In a competitive landscape dominated by protein supplements like Abbott’s Protality and Nestle Boost, ThymoTropin stands out with its clinically validated myostatin regulation mechanism. Unlike traditional products, ThymoTropin offers targeted efficacy without unnecessary calories or sugars, making it an ideal solution for modern health-conscious consumers.

Growing Market Opportunity and Competitive Landscape:

The global muscle health and nutritional support market are projected to exceed $15 billion by 2025, driven by increasing demand from ageing populations, oncology-supportive care, and weight management solutions. Competitor products such as Abbott’s Protality and Nestle Boost have collectively generated impressive sales, with:

• Protality generates an estimated annual revenue of $300 million and a 15% market share.
• Nestle Boost® generates an estimated $500 million annually with a 25% market share.
• Traditional whey protein supplements lead with over $8 billion in annual revenue and a dominant 60% market share.

While competitor products focus on general protein supplementation, ThymoTropin sets itself apart by targeting myostatin regulation, offering a precise and effective solution for muscle growth and preservation without unnecessary calories or sugars.

Available as an Ingredient for B2B Applications:

ThymoTropin is offered as a premium ingredient for business-to-business (B2B) formulations. This enables manufacturers in the health, nutrition, and functional food sectors to incorporate ThymoTropin’s proven myostatin-targeting benefits into their products, meeting growing consumer demand for advanced muscle health solutions. Veos Pharma partners with businesses to provide customized solutions and ensure seamless integration into existing product lines.

About Veos Pharmaceuticals:

Headquartered in Madrid, Spain, Veos Pharmaceuticals is a global leader in health innovation with a portfolio of nearly 40 products across the EU, US, and Canada. The company specializes in OTC solutions, biostimulants, and advanced nutritional products aimed at improving quality of life. Veos Pharma’s flagship products include Ocufresh®, BioPropello, OleoSorb, VEOX-Preserv, and ThymoTropin.

For more information, contact:

Dr. Bassam Damaj
Executive Chairman
Veos Pharmaceuticals, SL
Email: info@veospharma.com
Website: www.veospharma.com

Protality is a trademark of Abbott Laboratories. Boost® is a trademark of Nestlé

References:

www.grandviewresearch.com/industry-analysis/sports-supplement-market

Forward-Looking Statements: This press release may contain forward-looking statements that involve risks and uncertainties. Veos Pharmaceuticals assumes no obligation to update or revise these statements after the date of publication.

Media Contact

Organization: Veos Pharmaceuticals

Contact
Person: Dr. Bassam Damaj

Website:

https://www.veospharma.com/

Email:

info@veospharma.com

Contact Number: 34911925649

City: MADRID

Country:Spain

The post Veos Pharmaceuticals Unveils ThymoTropin to Support Muscle Health and Preservation During Weight Loss and Aging Journeys appeared first on
Brand News 24.
It is provided by a third-party content
provider. Brand News 24 makes no
warranties or representations in connection with it.